Article Text

Download PDFPDF
NICE guidance for identification and treatment of familial hypercholesterolaemia: Commentary 1

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: GAH is on the speaker panel and advisory boards for Pfizer, Astra-Zeneca and MSD. Additionally he has an unrestricted grant from Pfizer.